This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

E. PERRY McCULLAGH, M.D.; CHARLES E. RICHARDS, M.D.

AMA Arch Intern Med. 1951;87(1):4-16.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

HERTZ AND Roberts¹ in 1942 published the first report of patients treated with radioactive iodine. Although the results are difficult to interpret because of the almost simultaneous administration of I¹²⁷, their work forms a landmark in the medical application of the radioactive isotopes to the treatment of disease.

Early studies on both thyroid physiology and treatment of thyroid disease were accomplished by the use of the 12 hour isotope I¹³⁰.² In 1946 the availability of radioactive isotopes from the uranium chain-reacting pile was announced, and easy accessibility of the eight day isotope was made possible. The fact that I¹³⁰ would be displaced in treatment by I¹³¹ was recognized by Soley when he stated at the meetings of the American Goiter Association in 1949, "I have omitted the use of I¹³⁰. the 12.5 hour isotope, because probably it will no longer have a role in this type of . . . [Full Text PDF of this Article]

Author Affiliations
CLEVELAND

From the Cleveland Clinic and the Frank E. Bunts Educational Institute.

Footnotes
Read before the Section on Experimental Medicine and Therapeutics at the Ninety-Ninth Annual Session of the American Medical Association, San Francisco, June 29, 1950.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?